Diabetes type 1 vaccine - BioDiscovery
Alternative Names: Q-VaxLatest Information Update: 30 Mar 2007
At a glance
- Originator BioDiscovery; John Curtin School of Medical Research
- Class Antihyperglycaemics; Diabetes mellitus vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 1 diabetes mellitus
Most Recent Events
- 22 Aug 2002 This vaccine is still in active development for use in type 1 diabetes
- 03 Dec 1998 New profile
- 03 Dec 1998 Phase-II clinical trials for Type-1 diabetes mellitus in Australia (Parenteral)